Prognostic factors in response to anthracyclines
McCredie, K.B.; Keating, M.J.; Bodey, G.P.; Gehan, E.A.; Smith, T.; Freireich, E.J.
Cancer Treatment Reports 65(Suppl 4): 83-86
1981
ISSN/ISBN: 0361-5960 PMID: 6955014 Document Number: 176323
Document emailed within 1 workday
Related Documents
Martinón Sánchez F; Antelo Cortizas J; Morales Redondo R; Moreno Carretero E; Domínguez Granados R 2000: Analysis of prognostic factors for the antipyretic response to ibuprofen Anales Espanoles de Pediatria 53(5): 431-435Scolozzi, R.; Boccafogli, A.; Tocchetto, M.; Salmi, R.; Coletti, M.; Vicentini, L. 1983: Prognostic factors and response to chemotherapy in breast cancer. bibliographic review Minerva Medica 74(18): 1021-1031
Oriol, A.; Ribera, J.M.; Flores, A.; Batlle, M.; las Heras, G.; Vaquero, M.; Juncá, J.; Millá, F.; Feliu, E. 1995: Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients Medicina Clinica 104(8): 281-286
Rizzo, S.C.; Balduini, C.L.; Invernizzi, R.; Ricevuti, G.; Fontana, G.; Ascari, E. 1980: Prognostic factors and treatment response in acute lymphoblastic leukemia of children and adults treated with a non aggressive combination chemotherapy Haematologica 65(1): 70-81
Timovska, Y.O.; Pivnyuk, V.M.; Oliynichenko, G.P.; Anikushko, M.F.; Zachartseva, L.M.; Chekhun, V.F. 2009: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer Experimental Oncology 31(4): 231-236
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Di Filippo, F.; Giacomini, P.; Rossi, C.R.; Santinami, M.; Anzà, M.; Garinei, R.; Perri, P.; Botti, C.; Di Angelo, P.; Sofra, C.; Pasqualoni, R.; Sperduti, I.; Cavaliere, F.; Di Filippo, S.; Corrias, F.; Armenti, A.; Ferraresi, V.; Ginebri, A. 2009: Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion In Vivo 23(2): 347-352
Horiguchi, J.; Oyama, T.; Takata, D.; Rokutanda, N.; Nagaoka, R.; Odawara, H.; Tokiniwa, H.; Tozuka, K.; Kikuchi, M.; Sato, A.; Takeyoshi, I. 2011: Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience Anticancer Research 31(9): 3041-3046
Pasqualetti, P.; Colantonio, D.; Collacciani, A.; Casale, R.; Natali, G. 1991: Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications Panminerva Medica 33(2): 93-110
Busmanis, I. 1998: Biomarkers in carcinoma of the cervix: emphasis on tissue-related factors and their potential prognostic factors Annals of the Academy of Medicine Singapore 27(5): 671-675
Nieder, C.; Andratschke, N.; Jeremic, B.; Molls, M. 2003: Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer Anticancer Research 23(6d): 5117-5123
Bourienne, A.; Pagenault, M.; Heresbach, D.; Jacquelinet, C.; Faroux, R.; Lejean-Colin, I.; Person, B.; Masliah, C.; Nouel, O.; Seyrig, J.A.; Gosselin, M.; Bretagne, J.F. 2000: Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis Gastroenterologie Clinique et Biologique 24(2): 193-200
Jach, R.; Dyduch, G.; Radon-Pokracka, M.; Przybylska, P.; Mika, M.; Dulinska-Litewka, J.; Zajac, K.; Huras, H.; Streb, J.; Stangel-Wojcikiewicz, K.; Dziadek, O.; Galarowicz, B. 2011: Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer Neuro Endocrinology Letters 32(4): 530-539
Mayerhofer, K.; Tempfer, C.; Kucera, E.; Hefler, L.; Zeisler, H.; Kainz, C.; Zeillinger, R.; Sliutz, G. 1999: Humoral p53 antibody response is a prognostic parameter in ovarian cancer Anticancer Research 19(1b): 875-878
Reuter, V.E. 1990: Pathology of bladder cancer: assessment of prognostic variables and response to therapy Seminars in Oncology 17(5): 524-532
Sgambato, A.; Flamini, G.; Cittadini, A. 1996: New prognostic factors in oncology Rays 21(4): 559-572
Figarella-Branger, D.; Bouvier-Labit, C.; Liprandi, A.; Pellissier, J.F. 2000: Prognostic factors in meningiomas Annales de Pathologie 20(5): 438-447
Pariser, P.; Bergego, C. 1986: Prognostic factors in aphasia La Revue du Praticien 36(17): 981-986
Soloway, M.S. 1990: The importance of pretreatment testosterone and other prognostic variables in the response to androgen deprivation therapy Progress in Clinical and Biological Research 350: 141-148
Opasich, C.; Assandri, J.; Tramarin, R.; Pozzoli, M.; Traversi, E.; Febo, O.; Cobelli, F.; Specchia, G. 1983: Hypotensive response to the exercise test after recent myocardial infarct: prognostic implications Giornale Italiano di Cardiologia 13(9): 183-187